News Introduction

The effectiveness of 3,4-dihydroxybenzaldehyde(cas 139-85-5)

Date : 2016/8/9 10:36:17

The effectiveness(3,4-dihydroxybenzaldehyde(cas 139-85-5)) of traditional Chinese medicine in the form of multi-compound is reflected in Clinical Compatibility. The effectiveness of Chinese medicine also can be separated into two elements potency and efficacy interrelated, herbs and medicinal efficacy is reflected in the overall chemical complex integrated biological effects of chemical substances is a comprehensive reflection of the entire group's total property herbs, namely On the system of "total take" of "quality systems", and by no means alone in a single chemical component. Single component can not replace the original medicinal potency and efficacy, and "the whole is not a simple sum of the parts and." In fact, the presence of the chemical composition of the drug on human intervention in the pathological process of "network effect", the presence of multiple modes of interaction between the various components. 
Therefore, Chinese medicine is a comprehensive reflection of the quality of the biological effects of traditional Chinese medicine comprehensive chemical group. Ultimate effectiveness of traditional Chinese medicine for disease intervention (NIV) of the pathological process and, therefore, more targeted and purposeful. In accordance with the principle of traditional Chinese medicine clinical diagnosis and treatment of the compound in the form of application, the main (traditional Chinese medicine and the object (physiological and pathological patients) are two complex systems, traditional Chinese medicine prescriptions more "system quality effect", the system has the quality of Chinese Traditional Medicine "non-additivity" when compound Chinese medicine quality evaluation should be associated with the whole idea of prescription compatibility theory. 3,4-Dihydroxybenzaldehyde(cas 139-85-5) can be extracted from traditional Chinese medicine.
Due to historical reasons, a considerable number of "local standards" to "national standard" of species to be "Chinese Pharmacopoeia" collection contains quality "local standards" breed standard is low, including 3,4-dihydroxybenzaldehyde(cas 139-85-5), uneven level of product maturity. Even as varieties confidentiality reasons, or when the declaration of new drugs or confidential confidential process quality, some of the dose of each herb medicine unlisted, herbs or medicinal plants have a clear source of medicinal plant extracts does not disclose its source, because it is before Pharmacopoeia editions inherited problems, it has been extended to the 2015 edition. Unscientific, non-standard, or even wrong preparation process, quality standards can not be changed, to the merits of the quality of supervision and inspection difficult.